Clinical Trial Update: A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients [Phase 2]

View source ↗

Summary

Phase 2 trial results update on Efsubaglutide Alfa for overweight or obesity, reporting efficacy and safety outcomes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Efsubaglutide Alfa (efsubaglutide alfa)

Snippet

Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | Conditions: Overweight or Obesity | Phase 2 | Status: COMPLETED